human pulmonary artery smooth muscle cells (pasmc (Lonza)
Structured Review
Human Pulmonary Artery Smooth Muscle Cells (Pasmc, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pulmonary+artery+smooth+muscle+cells+(pasmc/human+primary+pulmonary+artery+smooth+muscle+cells++pasmcs+/us12030935-1083-25-32
Average 90 stars, based on 1 article reviews
Images
Related Articles
Inhibition:Article Title: Anti-PDGF-B antibodies and pharmaceutical composition thereof Article Snippet: .. Reagents The reagents used for testing for antibody or small molecule inhibition of human PDGF-BB, PDGF-AA, or PDGF-DD induced calcium flux using FLIPR or cellular proliferation in primary Cell Culture:Article Title: Cerivastatin Nanoliposome as a Potential Disease Modifying Approach for the Treatment of Pulmonary Arterial Hypertension Article Snippet: .. Antibody Labeling:Article Title: Anti-PDGF-B antibodies and pharmaceutical composition thereof Article Snippet: .. Reagents The reagents used for testing for receptor mediated antibody internalization in primary other:Article Title: NADPH oxidases and HIF1 promote cardiac dysfunction and pulmonary hypertension in response to glucocorticoid excess Article Snippet: Human microvascular endothelial cells (HMEC-1) (ATCC CRL-3243) and Article Title: Hypoxia selectively upregulates cation channels and increases cytosolic [Ca 2+ ] in pulmonary, but not coronary, arterial smooth muscle cells Article Snippet: Human pulmonary artery smooth muscle cells (PASMC) and Article Title: Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency Article Snippet: Primary pulmonary artery smooth muscle cells (PASMC) and human umbilical vein endothelial cells (HUVEC) were purchased from Lonza and grown in SmBM or |

![Excess BCAAs promoted a pro-ferroptotic phenotype in <t>human</t> <t>PASMC</t> . (A) Representative confocal micrographs of PASMC stained with MitoTracker Orange and quantification of mitochondrial organization in control and BCAA-treated PASMC (Control PASMC [Con]: 1.1±0.6, BCAA-Treated PASMC [BCAA]: 0.7±0.3); p -values determined by Mann-Whitney U-test. (B) Confocal micrographs of TRME-stained PASMC in control and BCAA-treated media, with corresponding quantification of mitochondrial membrane hyperpolarization, indicated by fluorescence intensity (Con: 8.3±17.2, BCAA: 42.7±9.7). p -values determined by Mann-Whitney U-test. (C) Excess BCAAs increase mitochondrial ROS, demonstrated by confocal micrographs of control and BCAA-treated PASMCs stained with MitoSox Red (Con: 6.4±2.1, BCAA: 14.5±6.9 MFI). p -values determined by Mann-Whitney U-test. (D) Representative confocal micrographs of control, BCAA-treated, and BCAA and ferrostatin-1-treated PASMCs incubated with 50 μM oleate and 50 μM palmitate and stained for lipid peroxidation using BODIPY (Con: 1.8±0.3, BCAA: 1.4±0.1, BCAA-treated with 5 μM ferrostatin-1 [BCAA-FER1]: 1.7±0.3). p -values determined by Kruskal-Wallis test and Dunn’s multiple comparisons test. (E) Incubation with BCAAs induces ferroptotic cell death, demonstrated by viability staining of control, BCAA-treated, and BCAA-treated with ferrostatin-1 PASMCs via Trypan Blue (Con: 9.4±7.5, BCAA: 31.7±11.7, BCAA-FER1: 13.0±11.1). White arrows indicate trypan blue-positive cells. p -values determined by ordinary one-way ANOVA with Tukey’s multiple comparison test.](https://bio-rxiv-images-cdn.bioz.com/dois_ending_with_19/10__1101_slash_2025__09__03__672819/10__1101_slash_2025__09__03__672819___F3.large.jpg)